FibroBiologics

Houston, United States

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

Jun 2026

Post-IPO Equity

Biopharma Biotechnology Pharmaceutical

Top Investors

Yorkville AdvisorsThe Global Emerging Markets Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about FibroBiologics

Who are FibroBiologics's investors?

FibroBiologics's investors include Yorkville Advisors, The Global Emerging Markets Group.

Where is FibroBiologics headquartered?

FibroBiologics is headquartered in Houston, United States.

What does FibroBiologics do?

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

What stage is FibroBiologics at?

FibroBiologics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 29, 2026.

MLA

"FibroBiologics — Funding & Investors." VCBacked, June 29, 2026, https://www.vcbacked.co/company/fibrobiologics. Accessed July 1, 2026.

APA

VCBacked. (2026). FibroBiologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/fibrobiologics

Wikipedia (cite web)

{{cite web |title=FibroBiologics — Funding & Investors |url=https://www.vcbacked.co/company/fibrobiologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 29, 2026.

Similar Companies in Biopharma

View all

Living In Silico Inc.

Crystalys Therapeutics

San Diego

ARS Pharmaceuticals

San Diego